...
首页> 外文期刊>Nanomedicine >Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells
【24h】

Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells

机译:用于癌症干细胞持续,受控和靶向治疗的纳米药物策略

获取原文
获取原文并翻译 | 示例

摘要

Cancer stem cells (CSCs) are original cancer cells that are of characteristics associated with normal stem cells. CSCs are toughest against various treatments and thus responsible for cancer metastasis and recurrence. Therefore, development of specific and effective treatment of CSCs plays a key role in improving survival and life quality of cancer patients, especially those in the metastatic stage. Nanomedicine strategies, which include prodrugs, micelles, liposomes and nanoparticles of biodegradable polymers, could substantially improve the therapeutic index of conventional therapeutics due to its manner of sustained, controlled and targeted delivery of high transportation efficiency across the cell membrane and low elimination by intracellular autophagy, and thus provide a practical solution to solve the problem encountered in CSCs treatment. This review gives briefly the latest information to summarize the concept, strategies, mechanisms and current status as well as future promises of nanomedicine strategies for treatment of CSCs.
机译:癌症干细胞(CSC)是原始癌细胞,具有与正常干细胞相关的特征。 CSC对各种治疗最为困难,因此会导致癌症转移和复发。因此,开发特异性和有效的CSC治疗方法在改善癌症患者,尤其是转移性癌症患者的生存和生活质量方面起着关键作用。纳米药物策略,包括前药,胶束,脂质体和可生物降解聚合物的纳米粒子,由于其持续,受控和靶向递送高效率穿过细胞膜的方式以及通过细胞内自噬的低消除方式,可以大大改善常规治疗剂的治疗指数。 ,从而为解决CSCs治疗中遇到的问题提供了实用的解决方案。这篇综述简要地提供了最新的信息,总结了用于治疗CSC的纳米药物策略的概念,策略,机制和现状以及未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号